Vertex Pharmaceuticals Inc / Ma
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/3/2026 | 256,008 | 0.2% | 566,227 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 213,435 | 0.2% | 544,978 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 233,697 | 0.2% | 524,925 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 237,109 | 0.2% | 489,067 | 3/31/2025 |
| 2024 Q4 | 2/12/2025 | 178,351 | 0.2% | 438,091 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 188,521 | 0.2% | 405,352 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 174,121 | 0.2% | 371,481 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 139,257 | 0.2% | 333,142 | 3/31/2024 |
| 2023 Q4 | 2/8/2024 | 113,116 | 0.2% | 275,415 | 12/31/2023 |
| 2023 Q3 | 11/7/2023 | 88,355 | 0.2% | 254,083 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 81,934 | 0.2% | 232,826 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 68,722 | 0.2% | 218,117 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 56,314 | 0.2% | 196,887 | 12/31/2022 |
| 2022 Q3 | 11/1/2022 | 51,535 | 0.2% | 177,989 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 45,480 | 0.2% | 161,398 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 38,688 | 0.2% | 148,247 | 3/31/2022 |
| 2021 Q4 | 2/7/2022 | 30,301 | 0.1% | 136,168 | 12/31/2021 |
| 2021 Q3 | 11/4/2021 | 21,121 | 0.1% | 116,439 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 21,189 | 0.1% | 105,091 | 6/30/2021 |
| 2021 Q1 | 5/6/2021 | 21,983 | 0.1% | 102,297 | 3/31/2021 |
| 2020 Q4 | 2/9/2021 | 21,390 | 0.2% | 90,505 | 12/31/2020 |
| 2020 Q3 | 11/10/2020 | 22,420 | 0.2% | 82,389 | 9/30/2020 |
| 2020 Q2 | 8/6/2020 | 18,717 | 0.2% | 64,472 | 6/30/2020 |
| 2020 Q1 | 5/11/2020 | 12,404 | 0.2% | 52,128 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 11,134 | 0.1% | 51,078 | 12/31/2019 |
| 2014 Q2 | 8/5/2014 | 4,348 | 0.1% | 45,924 | 6/30/2014 |
| 2014 Q1 | 5/7/2014 | 3,230 | 0.1% | 45,675 | 3/31/2014 |
| 2013 Q4 | 2/10/2014 | 3,169 | 0.1% | 43,139 | 12/31/2013 |